These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7908772)

  • 21. [Clinical and CT aspects of muscular dystonias].
    Quattrini A; Cinti F; Cianci F; Ortenzi A; Paggi A; Silvestri R
    Riv Patol Nerv Ment; 1982; 102(4):181-91. PubMed ID: 6127781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for the use of L-dopa in the torsion dystonias.
    Barbeau A
    Neurology; 1970 Nov; 20(11):96-102. PubMed ID: 4991253
    [No Abstract]   [Full Text] [Related]  

  • 23. Dystonia musculorum deformans: implications of therapeutic response to levodopa and carbamazepine.
    Garg BP
    Arch Neurol; 1982 Jun; 39(6):376-7. PubMed ID: 7092616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Functional state of non-specific brain systems in dystonia musculorum deformans].
    Veĭn AM; Golubev VL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):509-14. PubMed ID: 207060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of hyperkinesias in children.
    Mel'nichuk PV; Khokhlov AP; Khailova IM
    Neurosci Behav Physiol; 1984; 14(3):241-5. PubMed ID: 6144078
    [No Abstract]   [Full Text] [Related]  

  • 26. [Dystonia musculorum deformans. Favorable effect of bromocriptine].
    Gautier JC; Awada A
    Rev Neurol (Paris); 1983; 139(6-7):449-50. PubMed ID: 6612149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of dystonia musculorum deformans].
    Minich LN
    Zdravookhr Kirg; 1977; (3):30-3. PubMed ID: 22183
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of haloperiodol in torsion dystonia--a case report].
    Katsukawa K; Hosokawa K; Sano Y; Otsuka R
    Rinsho Shinkeigaku; 1976 May; 16(5):351-6. PubMed ID: 986272
    [No Abstract]   [Full Text] [Related]  

  • 29. Hereditary progressive dystonia with marked diurnal fluctuation.
    Segawa M; Hosaka A; Miyagawa F; Nomura Y; Imai H
    Adv Neurol; 1976; 14():215-33. PubMed ID: 945938
    [No Abstract]   [Full Text] [Related]  

  • 30. Preliminary remarks on the L-dopa therapy of dystonia.
    Coleman M
    Neurology; 1970 Nov; 20(11):114-21. PubMed ID: 5529473
    [No Abstract]   [Full Text] [Related]  

  • 31. [Familial dystonia transformed by the bromocriptine].
    Sabouraud O; Allain H; Pinel JF; Menault F
    Nouv Presse Med; 1978 Oct; 7(37):3370. PubMed ID: 733517
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pathogenesis of hyperkinesis in children].
    Mel'nichuk PV; Khokhlov AP; Khaĭlova IM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(10):1324-8. PubMed ID: 291244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status dystonicus a rare complication of dystonia.
    Mishra D; Singhal S; Juneja M
    Indian Pediatr; 2010 Oct; 47(10):883-5. PubMed ID: 21048241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-dopa reversal of muscular spasm, vomiting and insomnia in a patient with an atypical form of familial dystonia.
    Coleman MP; Barnet A
    Trans Am Neurol Assoc; 1969; 94():91-5. PubMed ID: 4313967
    [No Abstract]   [Full Text] [Related]  

  • 35. Levodopa in dystonia musculorum deformans.
    Rajput AH
    Lancet; 1973 Feb; 1(7800):432. PubMed ID: 4119748
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of dystonic symptoms with carbamazepine.
    Geller M; Kaplan B; Christoff N
    Adv Neurol; 1976; 14():403-10. PubMed ID: 941780
    [No Abstract]   [Full Text] [Related]  

  • 37. Apomorphine in dystonia musculorum deformans.
    Braham J; Sarova-Pinhas I
    Lancet; 1973 Feb; 1(7800):432-3. PubMed ID: 4119749
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dopa-responsive dystonia].
    Kaakkola S; Iivanainen M
    Duodecim; 1994; 110(13):1271-4. PubMed ID: 7497939
    [No Abstract]   [Full Text] [Related]  

  • 39. Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia.
    Greene P; Shale H; Fahn S
    Adv Neurol; 1988; 50():547-56. PubMed ID: 3400509
    [No Abstract]   [Full Text] [Related]  

  • 40. Quantitative evaluation of the effects of L-dopa in torsion dystonia: a case report.
    Richards CL; Bédard PJ; Fortin G; Malouin F
    Neurology; 1983 Aug; 33(8):1083-7. PubMed ID: 6683810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.